Applications of the genO‑hcGAS/TREX1D18N mouse model

Range of applications in the fields of inflammation and autoimmunity:

  • Assess the efficacy of cGAS or TREX1-targeting compounds
  • Gain insights into the mechanism of action (MOA) of diverse constructs and their potential therapeutic benefits

‍

Features

  • Physiological regulation and expression of humanized cGAS
  • The D18N mutation in TREX1 leads to the development of lupus-like pathology
  • Fully functional mouse immune system
  • Lack of expression of the murine target gene

‍

Guide: Compare cGAS/STING mouse models for drug assessment. Read the guide →

Clients

No items found.

Customize this model

Tailor this model to meet your research needs:

  • Assess the efficacy and safety of therapeutics with multiple humanized targets
  • Simultaneously evaluate efficacy, safety, and PK in a single model
  • Assess the impact of the human Fc-domain of an antibody while assessing its efficacy and safety
  • Increase tolerance to human IgG1

…and more to fit your program

Model Delivery & Care

  • Read our FAQ on delivery & care here
  • Orders are made directly with genOway; breeding, housing and delivery are outsourced
  • Breeding facilities in the US and Europe through our trusted partners:
  • Quick, compliant, and reliable door-to-door delivery worldwide
  • Models with certified SOPF health status from AAALAC-accredited and PHS-assured professional breeders

Baseline validation

  • Extended validation

  • Extended validation

Discover related products to

genO-hcGAS/TREX1 D18N

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
cGAS
cGAS-STING pathway

genO-hcGAS

The genO‑hcGAS mouse enables the in vivo efficacy assessment of agents and therapies targeting the cGAS–STING cytosolic DNA sensing pathway in fully immunocompetent mice.

Immune checkpoint
ICP (multi-target)
cGAS
cGAS-STING pathway
STING

genO-hcGAS/hSTING

The genO‑hcGAS/hSTING mouse enables the in vivo efficacy assessment of compounds targeting the human cGAS-STING pathway in fully immunocompetent mice.

STING
cGAS-STING pathway

genO-hSTING

The genO‑hSTING mouse enables the in vivo assessment of agents and therapies targeting the human STING in fully immunocompetent mice.

Preclinical Humanized genO‑hcGAS/TREX1 D18N Mouse Model

Get in touch about

Let us know how we can help

Scientific excellence

From model design to experimental results
Featured in 600+ scientific articles

Collaborative approach

Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions

Robust validation data on catalog models

Generated with biopharma partners and in-house

Innovative technologies

and guaranteed freedom to operate

Easy access to models

Models with certified health status from professional breeders in US and Europe